Key facts
- Megarobo’s last known valuation is $1.3B (Aug 2022).
- It has raised $580.3M; the latest was IPO in Jun 2025.
- Notable investors include CICC Capital, Innoangel Fund, Suzhou Guofa Venture Capital, Goldman Sachs Asset Management, Sinovation Ventures — 25 tracked in total.
- Status: In IPO Registration.
- ·The complete investor list — 25 names
- ·Watchlist + deal alerts for Megarobo
- ·The full record, as it builds
Funding rounds
No funding rounds for Megarobo are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Megarobo
Developer and provider of collaborative robots focusing on automation of life science research. The company specializes in developing flexible, efficient and practical automation solutions for life science companies and scientific research institutions, providing innovative laboratory services that aim to increase research efficiency.
- Sector
- Healthcare
- HQ
- Hangzhou, China
- Employees
- 915
- Website
- megarobo.tech/
- Ownership
- In IPO Registration
Megarobo doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Megarobo shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Megarobo in its N-PORT filings yet. We sweep new filings monthly.